NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$40.01
+1.36 (+3.52%)
At Close: Apr 19, 2024
Amphastar Pharmaceuticals to Release Second Quarter Earnings and Hold Conference Call on August 8, 2022
06:05am, Monday, 01'st Aug 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / August 1, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its second quarter of 2022 ended June 30, 2022, a
Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings
01:33pm, Tuesday, 26'th Jul 2022
Amphastar Pharmaceutcls is near a buy zone with earnings due on or around Aug. 9. The post Keep Amphastar Pharmaceuticals Stock On Your Watch List Ahead Of Earnings appeared first on Investor's Busine
Amphastar Pharmaceuticals to Present at the Jefferies Healthcare Conference
06:05am, Monday, 06'th Jun 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / June 6, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced today that Bill Peters, Executive V.P. and CFO, and Dan Dischner, V.P of Corporate Communicat
Amphastar Pharmaceuticals: Stock With An Attractive 6 To 1 Risk-Reward Ratio
02:22am, Friday, 13'th May 2022
Amphastar Pharmaceuticals has several key growth drivers: a strong pipeline of products currently awaiting approval, exciting products with growing sales, and growing marketing and distribution channe
7 Safe Small-Cap Stocks to Buy Now
10:25am, Thursday, 12'th May 2022
If you're looking for resilient plays with high upside potential, consider these seven safe small-cap stocks to buy. The post 7 Safe Small-Cap Stocks to Buy Now appeared first on InvestorPlace.
Has Amphastar Pharmaceuticals (AMPH) Outpaced Other Medical Stocks This Year?
01:40pm, Wednesday, 11'th May 2022 Zacks Investment Research
Here is how Amphastar Pharmaceuticals (AMPH) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Has Amphastar Pharmaceuticals (AMPH) Outpaced Other Medical Stocks This Year?
11:17am, Wednesday, 11'th May 2022
Here is how Amphastar Pharmaceuticals (AMPH) and Patterson Cos. (PDCO) have performed compared to their sector so far this year.
Amphastar Pharmaceuticals (AMPH) Q1 2022 Earnings Call Transcript
09:00am, Tuesday, 10'th May 2022 The Motley Fool
AMPH earnings call for the period ending March 31, 2022.
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
10:05pm, Monday, 09'th May 2022 Zacks Investment Research
Amphastar (AMPH) delivered earnings and revenue surprises of 42.42% and 8.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals (AMPH) Q1 Earnings and Revenues Top Estimates
07:33pm, Monday, 09'th May 2022
Amphastar (AMPH) delivered earnings and revenue surprises of 42.42% and 8.83%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q1 2022 Results - Earnings Call Transcript
06:29pm, Monday, 09'th May 2022
Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH ) Q1 2022 Earnings Conference Call May 9, 2022 5:00 PM ET Company Participants Dan Dischner - VP, Corporate Communications Bill Peters - CFO Conference Cal
Is a Surprise Coming for Amphastar Pharmaceuticals (AMPH) This Earnings Season?
12:50pm, Wednesday, 04'th May 2022 Zacks Investment Research
Amphastar Pharmaceuticals (AMPH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Is a Surprise Coming for Amphastar Pharmaceuticals (AMPH) This Earnings Season?
10:32am, Wednesday, 04'th May 2022
Amphastar Pharmaceuticals (AMPH) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Amphastar Pharmaceuticals to Release First Quarter Earnings and Hold Conference Call on May 9, 2022
04:05pm, Monday, 02'nd May 2022
RANCHO CUCAMONGA, CA / ACCESSWIRE / May 2, 2022 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced that the Company will release results for its first quarter of 2022 ended March 31, 2022, afte
3 Generic Drug Stocks to Watch Amid Continued Pricing Pressure
02:54pm, Monday, 02'nd May 2022 Zacks Investment Research
The impact of COVID-19 and continued pricing pressure on the Zacks Medical-Generic Drugs industry remains. New product launches may provide some respite for BHC, AMPH and SLGL.
